赚取进大学的费用
commented on
$Chagee Holdings (CHA.US)$ Why does it keep falling without recovery.
Translated
2
3
赚取进大学的费用
liked and commented on
赚取进大学的费用
liked
Today's operation: JD is a profitable closing, not a short sell. Chinese concept stocks are performing well, do you remember this test?
Translated


8
7
赚取进大学的费用
commented on
$Opendoor Technologies (OPEN.US)$ people saying buy should be working at casinos. this is a pump and dump. nothing more. unfortunately, there are uneducated people that lose money because of comments like the ones we see here.
4
15
赚取进大学的费用
commented on
Translated
3
赚取进大学的费用
liked and voted
by Steven GAO,
The US stock market's Q2 earnings season kicks off this week, led by three tech giants: TSM, ASML, and Netflix. ASML has just announced a disappointing earnings, causing the share price drop 8% pre-market. Yet the resumption of Nvidia's H20 chip sales to China has lifted the overhang on the chip sector's valuations, shifting investor sentiment toward optimism. Thus investors attentions are focus on TSM's report, set to be released...
The US stock market's Q2 earnings season kicks off this week, led by three tech giants: TSM, ASML, and Netflix. ASML has just announced a disappointing earnings, causing the share price drop 8% pre-market. Yet the resumption of Nvidia's H20 chip sales to China has lifted the overhang on the chip sector's valuations, shifting investor sentiment toward optimism. Thus investors attentions are focus on TSM's report, set to be released...



+4
56
24
14
赚取进大学的费用
liked and voted
Core Financial Performance: Exceeding Growth Expectations and Strategic Outlook Adjustment
Revenue and Profit Highlights
$Johnson & Johnson (JNJ.US)$ achieved Q2 2025 revenue of $23.74 billion (+5.8% YoY) and EPS of $2.29 (+18.7% YoY), both surpassing market expectations. J&J shares rose more than 6% at one point after the earnings disclosure.
The innovative pharmaceutical and Medtech businesses grew by 4.9% an...
Revenue and Profit Highlights
$Johnson & Johnson (JNJ.US)$ achieved Q2 2025 revenue of $23.74 billion (+5.8% YoY) and EPS of $2.29 (+18.7% YoY), both surpassing market expectations. J&J shares rose more than 6% at one point after the earnings disclosure.
The innovative pharmaceutical and Medtech businesses grew by 4.9% an...

5
赚取进大学的费用 : According to the trend of the Indicators, it will continue to decline.